KPTI (Karyopharm Therapeutics Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 33.12 million USD with EPS (earnings per share) anticipated at (1.31) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported37.93 M44.04 M34.08 M35.07 M— | Revenue Estimate38.03 M42.06 M35.10 M31.40 M33.12 M | Revenue Surprise-0.28%+4.71%-2.92%+11.68% | EPS Reported(4.32)(3.82)(5.71)(1.24) | EPS Estimate(4.08)(3.47)(1.99)(1.42)(1.31) | EPS Surprise-5.84%-10.23%-186.32%+12.50% |